Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Remote Monitoring to Improve Transitioning Home and Reducing Risk of Readmission

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio


Follow This Show

If you liked this show, you should follow Pharma Talk Radio.

In this session recorded at DPHARM 2022, Memorial Sloan Kettering Cancer Center shares about their Connected Care protocol.

Digital monitoring of patients has the potential to better the delivery of cancer care through improved patient-provider communication, enhanced symptom and toxicity assessment and management, and optimized engagement across the cancer continuum. Remote monitoring is especially crucial when patients are at high risk for experiencing symptoms or toxicities from treatment. During these episodes, patients and clinicians benefit from routine assessments of electronic patient-reported outcomes (ePROs) to identify symptoms early and prevent adverse outcomes. The Connected Care protocol provides remote monitoring to medical oncology patients for 10-days post hospital discharge as this is a high-risk period for patients due to a lingering symptom burden and a need for enhanced patient-clinician communication as symptom management shifts from the inpatient to outpatient team. Specifically, Dr. Daly will discuss:

  • The feasibility and acceptability of remote monitoring in the post discharge setting for patients with cancer
  • Patient perspectives for remote monitoring post hospital discharge
  • ePRO versus device and challenges with implementation
  • Thoughts on the right data to collect and at what intervals


  • Robert Daly, MD, MBA, Assistant Attending Medical Oncologist, Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled